Stockscreener 앱 받기
0.8204
0.93%
-0.0077
시간 외 거래:
.82
-0.0004
-0.05%
전일 마감가:
$0.8281
열려 있는:
$0.82
하루 거래량:
63,094
Relative Volume:
0.29
시가총액:
$73.59M
수익:
-
순이익/손실:
$-30.15M
주가수익비율:
-0.9015
EPS:
-0.91
순현금흐름:
$-31.63M
1주 성능:
-2.33%
1개월 성능:
+17.20%
6개월 성능:
-2.57%
1년 성능:
-64.02%
1일 변동 폭
$0.81
$0.84
1주일 범위
$0.81
$0.88
52주 변동 폭
$0.49
$2.5899
Context Therapeutics Inc Stock (CNTX) Company Profile
명칭
Context Therapeutics Inc
전화
267-225-7416
주소
2001 MARKET STREET, PHILADELPHIA
CNTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CNTX
Context Therapeutics Inc
|
0.8204 | 74.28M | 0 | -30.15M | -31.63M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Context Therapeutics Inc Stock (CNTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-21 | 개시 | William Blair | Outperform |
| 2025-01-08 | 개시 | JMP Securities | Mkt Outperform |
| 2024-11-25 | 개시 | D. Boral Capital | Buy |
| 2024-05-16 | 개시 | Piper Sandler | Overweight |
Context Therapeutics Inc 주식(CNTX)의 최신 뉴스
Market reaction to Context Therapeutics Inc.’s recent newsQuarterly Trade Review & Reliable Entry Point Alerts - Newser
Can Context Therapeutics Inc. navigate macro headwindsWeekly Volume Report & Comprehensive Market Scan Insights - خودرو بانک
Price action breakdown for Context Therapeutics Inc.Weekly Earnings Recap & Proven Capital Preservation Tips - Newser
Using Python tools to backtest Context Therapeutics Inc. strategiesPortfolio Update Report & High Yield Stock Recommendations - Newser
Is Context Therapeutics Inc. a play on infrastructure spendingMarket Weekly Review & Technical Entry and Exit Tips - خودرو بانک
Applying sector rotation models to Context Therapeutics Inc.July 2025 Patterns & Capital Efficiency Focused Ideas - Newser
News impact scoring models applied to Context Therapeutics Inc.2025 Buyback Activity & Reliable Momentum Entry Alerts - Newser
Can momentum traders help lift Context Therapeutics Inc.Weekly Investment Recap & Community Verified Trade Alerts - Newser
Visual analytics tools that track Context Therapeutics Inc. performance2025 Risk Factors & Reliable Momentum Entry Alerts - Newser
Quantitative breakdown of Context Therapeutics Inc. recent moveJuly 2025 Drop Watch & Daily Market Momentum Tracking - Newser
Context Therapeutics Inc. Nearing Breakout Level After BounceJuly 2025 Chart Watch & Free Real-Time Volume Trigger Notifications - beatles.ru
Chart based exit strategy for Context Therapeutics Inc.Trade Risk Assessment & Precise Entry and Exit Recommendations - Newser
What analysts say about Context Therapeutics Inc. stock outlook2025 Winners & Losers & Risk Managed Investment Strategies - Newser
Measuring Context Therapeutics Inc.’s beta against major indicesPortfolio Gains Report & Comprehensive Market Scan Reports - Newser
Tools to monitor Context Therapeutics Inc. recovery probabilityTrade Signal Summary & Daily Profit Maximizing Tips - Newser
Does Context Therapeutics Inc. qualify in momentum factor screeningJuly 2025 Reactions & Technical Entry and Exit Alerts - Newser
Order flow analysis tools used on Context Therapeutics Inc.2025 Market Outlook & Weekly High Conviction Ideas - Newser
How to forecast Context Therapeutics Inc. trends using time seriesJuly 2025 Selloffs & Free AI Powered Buy and Sell Recommendations - Newser
Analyzing drawdowns of Context Therapeutics Inc. with statistical toolsRecession Risk & Low Risk High Reward Ideas - Newser
Signal strength of Context Therapeutics Inc. stock in tech scannersNew Guidance & High Accuracy Trade Signal Alerts - Newser
Best data tools to analyze Context Therapeutics Inc. stockQuarterly Trade Report & Step-by-Step Swing Trade Plans - Newser
Can Context Therapeutics Inc. stock outperform in a bear marketJuly 2025 Volume & Verified Chart Pattern Trade Signals - خودرو بانک
Published on: 2025-09-02 23:32:31 - Newser
Guidance Update: Can Context Therapeutics Inc. navigate macro headwindsWeekly Trend Summary & Free High Return Stock Watch Alerts - خودرو بانک
Earnings visualization tools for Context Therapeutics Inc.Short Setup & Accurate Buy Signal Alerts - Newser
Short interest data insights for Context Therapeutics Inc.Earnings Beat & Verified High Yield Trade Plans - Newser
Context Therapeutics Inc. Inches Toward Key Resistance — Will It Break2025 Valuation Update & AI Forecast Swing Trade Picks - beatles.ru
Will Context Therapeutics Inc. rebound enough to break evenJuly 2025 Closing Moves & High Accuracy Trade Alerts - Newser
Context Therapeutics Granted Nasdaq Extension for Compliance - TipRanks
Is Context Therapeutics Inc. in a long term uptrendJuly 2025 Technicals & Daily Stock Trend Reports - خودرو بانک
Is Context Therapeutics Inc. forming a reversal patternWeekly Investment Summary & Safe Capital Growth Tips - Newser
Stock Recap: Is Context Therapeutics Inc. stock showing strong momentumJuly 2025 Volume & High Accuracy Investment Entry Signals - خودرو بانک
Can Context Therapeutics Inc. be the next market leaderJuly 2025 Weekly Recap & Free Weekly Watchlist of Top Performers - خودرو بانک
Is Context Therapeutics Inc. stock showing strong momentumEarnings Overview Summary & Pattern Based Trade Signal System - خودرو بانک
What is the PEG ratio of Context Therapeutics Inc.Weekly Profit Summary & Weekly Breakout Watchlists - خودرو بانک
Context Therapeutics Inc. Matches Institutional Buying Filter2025 Earnings Impact & Free AI Powered Buy and Sell Recommendations - beatles.ru
Context Therapeutics Inc (CNTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Context Therapeutics Inc 주식 (CNTX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Levit Alex C. | Chief Legal Officer, Corp. Sec |
Jun 06 '25 |
Buy |
0.58 |
20,000 |
11,520 |
29,000 |
| Minai-Azary Jennifer Lynn | Chief Financial Officer |
Jun 06 '25 |
Buy |
0.64 |
40,010 |
25,486 |
80,010 |
1.40%
자본화:
|
볼륨(24시간):